Bladder cancer patients rarely receive recommended care

	Tweet

A new study has found that almost all patients with high-grade noninvasive bladder cancer do not receive complete care as recommended by current guidelines. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to identify and overcome barriers to providing optimal care to patients with bladder cancer.

High-grade noninvasive bladder cancer has up to a 70 percent chance of recurring after treatment and up to a 50 percent chance of progressing to a more invasive tumor. Effective treatment for patients with high-grade noninvasive bladder cancer is critical. If the bladder tumor recurs and remains noninvasive, patients must undergo multiple operations; if it recurs and progresses to an invasive cancer, patients are at risk of having the cancer spread, and they may need to have their bladder removed and undergo radiation and chemotherapy treatments.

Medical guidelines advocate for delivering anticancer chemotherapy directly into the bladder (intravesical therapy) in order to minimize recurrence and progression of bladder cancer. They also recommend an intense follow-up schedule involving the use of a scope to evaluate the bladder (cytoscopy) and a urine test (cytology) every three months. 

To see whether patients are actually receiving this recommended care, Karim Chamie, MD, MSHS of the University of California Los Angeles led a team of researchers from UCLA’s Jonsson Comprehensive Cancer Center that analyzed information on 4,545 patients diagnosed with high-grade noninvasive bladder cancer from 1992 to 2002 whose data were contained in the Surveillance, Epidemiology and End Results (SEER)-Medicare database, which links cancer registry information to a master file of Medicare enrollment. “To our surprise, out of the 4,545 patients, only one received care that was compliant with all the guideline recommendations,” said Dr. Chamie. “In addition, nearly half of urologists have not performed at least one cystoscopy, one cytology, and one instillation of intravesical therapy for any given patient in the first two years after diagnosis.”

The researchers measured whether patients’ age, race, socioeconomic status, severity of other medical conditions, and extent of their bladder cancer contributed to the low compliance rate with guideline recommendations. They discovered that these patient-level factors had little effect. Rather, the most important predictor of whether a patient underwent recommended care was the physician. Additional studies are needed to identify why the vast majority of physicians are not following medical guidelines related to bladder cancer.

Based on these findings, “one would deduce that more than 99 percent of patients with high-risk bladder cancer are not receiving recommended care. This is significantly less than what most patients with bladder cancer, their physicians, and policy makers believe is happening,” said Dr. Chamie. “We hope that shedding light on the level of discordance between ideal and routine care will prompt policy makers to modify reimbursement policies or support quality-improvement initiatives in the future.”

###

Contact: Jennifer Beal

44-012-437-70633
Wiley-Blackwell

RELATED STORIES:
Blood test may find markers of bladder cancer risk   Bladder cancer: Need for a standardized protocol of management   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Home urine testing cuts bladder cancer deaths   The Predictors of Local Recurrence After Radical Cystectomy in Patients with Invasive Bladder Cancer   Survival and Response to Therapy of Non-Invasive Bladder Cancer Patients   Women in nursing homes often have bladder problems   Less bladder cancer in frequent painkiller users   More Intense Bladder Cancer Treatment Does Not Improve Survival   Brochure Helps Patients Understand Treatments for Bladder Cancer   Stanford computer algorithm used to identify bladder cancer marker   Sales jobs tied to bladder cancer risk   Selenium May Prevent High Risk-Bladder Cancer   Retired firefighters could be at increased risk for developing bladder cancer   Variation in prostate stem cell antigen gene raises bladder cancer risk   UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings   Estrogen use tied to bladder control problems   New Investigational Treatment for Bladder Cancer, Identified with New Research Model   Nearly all patients with high-grade bladder cancer do not receive guideline-recommended care   Patients unaware of link between smoking and bladder cancer   Chemicals in meat may be linked to bladder cancer   Bladder cancer: A difficult problem?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]